Improving models to study the human heart retrieved 24 May 2024 from https://medicalxpress.com/news/2024-05-human-heart.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.May 22, 2024Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Source: Healthcare Press (healthcarepress.net)
Medicine Research Health Research News Health Research Health Science Medicine Science
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Improving the safety of iPS cell-derived pancreatic islets by eliminating unwanted cellsA team of researchers has uncovered the identity of off-target cells responsible for abnormal outgrowth and devised a method to eliminate them from iPS cell-derived pancreatic tissues in development for cell therapy against type 1 diabetes.
Source: medical_xpress - 🏆 101. / 51 Read more »
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeuticClosed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced...
Source: NewsMedical - 🏆 19. / 71 Read more »
Tumor tissue on a chip: New possibilities for cell therapies and personalized medicineHow do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as for the doctors treating them.
Source: medical_xpress - 🏆 101. / 51 Read more »
Studies reveal cell-by-cell changes caused when pig hearts and kidneys are transplanted into humansSurgical teams at NYU Langone Health performed the world's first genetically modified pig kidney transplant into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022.
Source: medical_xpress - 🏆 101. / 51 Read more »
New PET imaging agent shows promise in visualizing lesions in clear cell renal cell cancer patientsA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of The Journal of Nuclear Medicine.
Source: NewsMedical - 🏆 19. / 71 Read more »
New PET agent provides same-day imaging for clear cell renal cell carcinoma patientsA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of The Journal of Nuclear Medicine.
Source: medical_xpress - 🏆 101. / 51 Read more »